Mark:

DIABOT

Status Date:

01-17-2022

Registration Number:

N/A

Goods and Services:

Computer hardware and software for collecting, receiving, processing, transmitting and displaying medical patient information and data via telecommunication and global computer networks to a central repository for storage and remote access; computer operating systems for medical devices; computer software for use with glucose sensors, namely, software for recording blood test results from a blood glucose monitor, for communicating with other devices, for controlling other medical devices, for functioning as a hypervisor, for providing security functions, and for providing a general purpose computing platform; downloadable computer software application for diabetes monitoring, management and maintenance; computer hardware and networking apparatus for wireless communications systems for medical devices; computer software for wireless communications systems for medical devices, namely, software for transmitting and analysis of medical device data, for providing secure communications, for communicating with other medical devices, for controlling other devices, for transmitting power wirelessly, and for communicating with local networks, mobile networks, and global communication networks; computer hardware, software and firmware for controlling and interconnecting medical devices and mobile communication devices; computer hardware and software hypervisors Medical apparatus and instruments for diagnosing, monitoring, and treating diabetes; Medical devices for administering drugs, namely, diabetes management devices in the nature of injection devices, infusion pumps, infusion pump controllers and parts and attachments thereof; medical devices, namely, medical sensors that are implanted or inserted into the human body used to continuously monitor the concentration of glucose in the human body and accessories therefor, namely, receivers, sensor housings and sensor insertion devices; medical devices, namely, devices used to draw blood for glucose testing and diabetes management

Class:

Surgical

Published for Opposition Date:

10-16-2018

Mark Drawing Status:

Standart Character Mark

Business Name:

MORRISON & FOERSTER LLP